Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis

Bibliographic Details
Main Authors:	Shuang Dai, Yuanliang Yan, Zhijie Xu, Shuangshuang Zeng, Long Qian, Lei Huo, Xuejun Li, Lunquan Sun, Zhicheng Gong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-11-01
Series:	Frontiers in Pharmacology
Subjects:	glioblastomas temozolomide resistance SCD1 Akt signaling
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2019.01358/full

Internet